BBUC vs LGN stock comparison
Brookfield Business vs. Legence · data as of November 13, 2026
Brookfield Business (BBUC) has a market value of about $6.0B, Legence (LGN) about $5.4B. Over their latest twelve months Brookfield Business had revenue of $27.0B and Legence $4.3B.
On our five checks Legence scores higher: 1.2 out of 5 (weak) against 1.0 (weak).
By area, the stronger company is Legence on value; Legence on future growth; Brookfield Business on shareholder returns.
Legence is cheaper on earnings (P/E 89.7 vs. 267.8).
Brookfield Business leads on 9 of the compared lines and Legence on 11.
Side by side
| BBUC | LGN | |
|---|---|---|
| Size and price | ||
| Market cap | $6.0B | $5.4B |
| Share price | $28.68 | $35.00 |
| Score | ||
| Overall score (of 5) | 1.0 | 1.2 |
| Value | 1 | 2 |
| Future growth | 1 | 2 |
| Track record | 0 | 0 |
| Financial health | 1 | 1 |
| Shareholder returns | 2 | 1 |
| Valuation | ||
| P/E (TTM) | 267.8 | 89.7 |
| Forward P/E | 15.0 | 13.9 |
| Price / free cash flow | 3.1 | 18.2 |
| Price / sales | 0.2 | 1.2 |
| EV / EBITDA | 4.9 | 21.2 |
| PEG | 17.19 | — |
| DCF value vs. price | −18% | +91% |
| Business | ||
| Revenue | $27.0B | $4.3B |
| Net income | $22M | $45M |
| Free cash flow | $1.9B | $298M |
| Net margin | 0.1% | 1.0% |
| Gross margin (5-yr avg.) | 26.3% | 20.3% |
| ROIC (5-yr avg.) | 5.0% | 3.6% |
| Growth | ||
| Revenue growth (1 yr) | -26.2% | 21.5% |
| Revenue growth (5 yrs, per year) | -1.1% | — |
| EPS growth (5 yrs, per year) | — | — |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$26.7B | -$859M |
| Dividend yield | 0.87% | None |
| Shareholder yield | 0.9% | 0.0% |
| Analysts | ||
| Upside to average target | +31% | +106% |
| Consensus rating | Buy | Strong buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: BBUC TTM to September 30, 2026, LGN TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Brookfield Business or Legence?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Legence scores 1.2 out of 5 and Brookfield Business 1.0; the table shows where each one is stronger.
Is Brookfield Business cheaper than Legence?
On trailing earnings, Legence trades at a P/E of 89.7 and Brookfield Business at 267.8, so Legence is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which pays a higher dividend?
Brookfield Business yields 0.87% and Legence nothing (no dividend).
Full Brookfield Business analysis → Full Legence analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.